Lamictal

Lamotrigine, the active ingredient in Lamictal, is a sodium channel blocker presented as an oral tablet for oral use. It is prescribed to manage epilepsy, including various seizure types, and to stabilize mood in bipolar disorder for adults and adolescents.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for this essential medication through established logistics networks, ensuring timely delivery to diverse healthcare settings.

Lamotrigine is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

Epilepsy: reduces the frequency and severity of seizures in patients with focal and generalized epilepsy. Bipolar disorder: helps maintain mood stability and prevents depressive and manic episodes in adults and adolescents. Partial seizures: decreases occurrence of focal onset seizures when used as adjunct therapy. Generalized seizures: contributes to control of tonic‑clonic seizures as part of combination therapy.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea or vomiting - Skin rash - Insomnia - Blurred vision

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe skin reactions (e.g., bullous eruptions) - Blood dyscrasias such as agranulocytosis - Hepatic failure - Suicidal thoughts or behavior

When prescribing lamotrigine, clinicians should consider several safety measures.

Monitor blood counts: regular hematologic testing is advised to detect rare blood abnormalities. Assess skin reactions: patients should be instructed to report any rash promptly. Adjust dose with valproate: co‑administration requires slower titration to avoid toxicity. Avoid abrupt discontinuation: tapering is recommended to reduce seizure recurrence risk. Store at room temperature: keep in the original packaging, protect from moisture and excessive heat.

Lamotrigine interacts with several medications that can alter its plasma levels.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations. - Carbamazepine: reduces lamotrigine levels, potentially decreasing efficacy. - Phenytoin: accelerates lamotrigine metabolism, lowering therapeutic effect.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may reduce lamotrigine levels, requiring dose adjustment. - Serotonergic antidepressants (e.g., SSRIs): monitor for increased risk of serotonin syndrome. - NSAIDs: may slightly increase lamotrigine exposure; observe for enhanced side effects.